What can we learn from the phenomenon of preferential lymph node metastasis in carcinoma?

Journal of Surgical Oncology

Volumn 70, Issue 3, 1999, Pages 199-204

  Gendreau, Kelly M ^a   Whalen, Giles F ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Lymphatic environment; Preferential lymph node metastasis; Primary epithelial tumor

Indexed keywords

CELL ADHESION MOLECULE;

CANCER IMMUNOLOGY; CARCINOGENESIS; CARCINOMA; CELLULAR IMMUNITY; HUMAN; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVIEW;

ANTIGENS, CD44; CARCINOMA; CELL ADHESION MOLECULES; CELL DIVISION; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASMS;

EID: 0032973650     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199903)70:3<199::AID-JSO11>3.0.CO;2-0     Document Type: Review

References (60)

1. Willis RA: "The Spread of Tumours in the Human Body." London: Camelot Press, 1973.
2. Foster R: General anatomy of the lymphatic system. Surg Oncol Clin North Am 1996;5:1-13.
3. Henry K, Farrer-Brown G: "Color Atlas of Thymus and Lymph Node Histopathology." Chicago: Year Book, 1982.
4. Girard JP, Springer T: High endothelial venules (HEVs): Specialized endothelium for lymphocyte migration. Immunol Today 1995:16:449-457.
5. Weiss L: The pathohiology of metastasis within the lymphatic system. Surg Oncol Clin North Am 1996;5:15-24.
6. Ishida K, Katsuyama T, Sugiyama A, et al.: Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069-1076.
7. Whalen G, Sharif S: Locally increased metastatic efficiency as a reason for preferential metastasis of solid tumors to lymph nodes. Ann Surg 1992;215:166-171.
8. Arita T. Matsumoto T, Kuramitsu T. et al.: Is it possible to differentiate malignant mediastinal nodes from benign nodes By size? Chest 1996;110:1004-1008.
9. Ayhan A, Tuncer S. Tuncer R. et al.: Tumor status of lymph nodes in early endometrial cancer in relation to lymph node size. Eur J Obstet Gynecol Reprod Biol 1995;60:61-63.
10. Fisher B, Fisher ER: The significance of the interrelationship of lymph and blood vascular system in tumor cell dissemination. In Ariel IM (ed): "Progress in Clinical Cancer." New York: Grune & Stratton, 1968:84-96.
11. Liotta L: Biochemical mechanisms of tumor invasion and metastases. Adv Exp Med Biol 1988;233:161-169.
12. Weidner N, Semple J, Welch W, et al.: Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
13. Alex J, Krag D: The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin North Am 1996;5: 33-41.
14. McMasters K, Giuliano A, Ross M, et al.: Sentinel lymph node biopsy for breast cancer - Not yet the standard of care. N Engl J Med 1998;339:990-995.
15. Ross M: Lymphatic mapping and sentinel node biopsy for early stage melanoma: How we do it at the M.D. Anderson Cancer Center. J Surg Oncol 1997;66:273-276.
16. Tanabe K, Reintgen D: The role of sentinel lymph node mapping for melanoma. Adv Surg 1998;31:79-103.
17. Giuliano A, Dale P, Turner R, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394-401.
18. Nicholson G: Tumor and host molecules important in organ preference of metastasis. Semin Cancer Biol J 1991;2:143-154.
19. Yeatman J, Nicolson G: Molecular basis of tumor progression: Mechanisms of organ-specific tumor metastases. Semin Surg Oncol 1993;9:256-262.
20. Kinsey DL: An experimental study of preferential metastasis. Cancer 1960;13:674-676.
21. Folkman J: Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
22. Liotta L: Tumor invasion and metastasis: Role of the basement membrane. Am J Pathol 1984;117:339-348.
23. Fidler I, Kripke M: Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-895.
24. Wallace A, Hollenburg N: The transplantability of tumors by intravenous and intralymphatic routes. Br J Cancer 1965;19:338.
25. Weiss L: Metastatic inefficiency. Adv Cancer Res 1990;54:159.
26. Cumberbatch M, Dearman R, Kimber I: Adhesion molecule expression by epidermal Langerhans cells and LN dendritic cells: A comparison. Arch Dermatol Res 1996;288:739-744.
27. Price A, Cumberbatch M, Kimber I, et al.: Alpha-6 integrins are required for Langerhans cell migration from epidermis. J Exp Med 1997;186:1725-1735.
28. Streit M, Schmidt R, Hilgenfeld R, et al.: Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. Recent Results Cancer Res 1996;142:19-50.
29. Lee E, Woo H, Korzelius C, et al.: Carbohydrate-binding protein 35 is the cell-surface laminin-binding protein in colon cancer. Arch Surg 1991;126:1498-1502.
30. Islam S, Whalen G, Sharif S: Inhibition of tumor cell adhesion to lymph nodes by laminin-related peptide and neuraminidase. Surgery 1993;113:676-682.
31. Kupiec-Weglinski J, De Sousa M: Lymphocyte traffic is modified in vivo by anti-laminin antibody. Immunology 1991;72:312-313.
32. Miyake K, Underhill C, Lesley J, et al.: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172:69-75.
33. Aruffo A, Stamenkovic M, Underhill C. et al.: CD44 is the principle cell surface receptor for hyaluronate. Cell 1990;61:1303-1313.
34. Naot D, Sionov R, Ish-Shalom D: CD44: Structure, function, and association with the malignant process. Adv Cancer Res 1997;71: 241-319.
35. Fox S, Fawcett J, Jackson D, et al.: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994;54:4539-4546.
36. Arch R, Wirth K, Hofmann M, et al.: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992;257:682-685.
37. Hynes R: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992:69:11-25.
38. Clark R, Alon R, Springer T: CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 1996;134:1075-1087.
39. Nip J, Sibata H, Loskutoff DJ, et al.: Human melanoma cells derived from lymphatic metastases use integrin alpha-5 beta-3 to adhere to lymph node vitronectin. J Clin Invest 1992;90:1406-1413.
40. Bafetti L, Young T, Itoh Y, et al.: Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J Biol Chem 1998;273:143-149.
41. Whalen G, Gordon C, Yeshion C, et al.: Influence of a lymph node environment on invasiveness of metastatic tumor cells. J Am Coll Surg 1994;179:145-150.
42. Clarke M, Landreneau R, Finkelstein S, et al.: Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung. Hum Pathol 1997;28:54-59.
43. Gehlsen K, Argraves S, Pierschbacher M, et al.: Inhibition of in vitro tumor cell invasion by arg-gly-asp-containing synthetic peptide. J Cell Biol 1988;106:925-930.
44. Porte H, Chastre E, Prevot S, et al.: Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 1995;64: 70-75.
45. Broll R, Meyer S, Neuber M, et al.: Expression of tenascin in tumors of the esophagus, small intestine, and colorectum. An immunohistochemical study. Gen Diagn Pathol 1995;141:111-119.
46. Picker L, Terstappen L, Rott L, et al.: Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol 1990;145:3247-3255.
47. Abbas A, Murphy K, Sher A: Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
48. Brown D, Moskowitz N, Killeen N, et al.: A role for CD4 in peripheral T cell differentiation. J Exp Med 1997;186:101-107.
49. Fitch F, McKisic M, Lancki D, et al.: Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993;11:29-48.
50. Mossmann T, Coffman R: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
51. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998;8:275-283.
52. Curfs J, Meis J, Hoogkamp-Korstanje J: A primer on cytokines: Sources, receptors, effects, and inducers. Clin Microbiol Rev 1997;10:742-780.
53. Aruga A, Aruga E, Cameron M, et al.: Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression. J Leukocyte Biol 1997; 61:507-516.
54. Passlick B, Pantel K, Kubuschok B, et al.: Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: Association with early lymphatic spread of tumour cells. Eur J Cancer 1996;32A:141-145.
55. Holzmann B, Gosslar U, Bittner M: α4 integrins and tumor metastasis. Curr Top Microbiol Immunol 1998;231:125-141.
56. Shimizu Y, Newman W, Gopal T, et al.: Four molecular pathways of T cell adhesion to endothelial cells: Roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under differential activation conditions. J Cell Biol 1991;113:1203-1212.
57. Lawrence M, Springer T: Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859-873.
58. Apasov S, Redegeld F, Sitkovsky M: Cell-mediated cytotoxicity: Contact and secreted factors. Curr Opin Immunol 1993;5:404-410.
59. Bridoux F, Badou A, Saoudi A, et al.: Transforming growth factor β-dependent inhibition of T helper cell 2-induced autoimmunity by self major histocompatibility complex class II-specific, regulatory CD4+ T cell lines. J Exp Med 1997;185:1769-1775.
60. Barbera-Guillem E, Arnold M, Nelson B. et al.: First results for resetting the antitumor immune response by immune corrective surgery in colon cancer. Am J S 1998;176:339-343.